Delayed vs early cardioversion in patients with paroxysmal atrial fibrillation: a population-based study (2015-2020)

Authors

Mohamed Salah Mohamed, Rochester Regional HealthFollow
Anas Hashem, Rochester Regional HealthFollow
Amani Khalouf, Rochester Regional HealthFollow
Muhammad Osama, Rochester Regional HealthFollow
Venkata Satish Pendela, Rochester Regional HealthFollow
Devesh Rai, Rochester Regional HealthFollow
Wilbert S. Aronow, Department of Cardiology, Westchester Medical Center & New York Medical College, NY, USA.
Mallory Balmer-Swain, Rochester Regional HealthFollow

Department

Internal Medicine

Document Type

Article

Publication Title

Future Cardiology

Abstract

There is limited data on clinical outcomes of delayed cardioversion (DCV) compared with early cardioversion (ECV) in paroxysmal atrial fibrillation (AF) patients. We utilized data from National Inpatient Sample (2015-2020) and propensity-score matched analysis to determine adjusted odds ratio (aOR) of major clinical outcomes, including 17,879 AF cases: 9725 and 8154 underwent ECV and DCV, respectively. Compared with ECV, DCV was associated with higher odds of acute heart failure (AHF; aOR 1.79 [1.67-1.92]; p < 0.01), median length of stay (4 vs 2 days; p < 0.01) and cost of hospitalization ($33,410 vs $21,738; p < 0.01) with no significant difference in inpatient mortality and other cardiovascular and neurological outcomes. Compared with ECV, DCV was associated with more AHF and resource utilization.

First Page

441

Last Page

452

DOI

10.2217/fca-2023-0069

Volume

19

Issue

9

Publication Date

7-1-2023

PubMed ID

37650496

Recommended Citation

Mohamed, M. S., Hashem, A., Khalouf, A., Osama, M., Pendela, V. S., Rai, D., Aronow, W. S., & Balmer-Swain, M. (2023). Delayed vs early cardioversion in patients with paroxysmal atrial fibrillation: a population-based study (2015-2020). Future Cardiology, 19 (9), 441-452. https://doi.org/10.2217/fca-2023-0069